U.S. Senator Wyden Continues Investigation into Big Pharma Tax Avoidance Practices

U.S. Senate Finance Committee Chair Ron Wyden (D-OR) issued a release on 18 January 2022 regarding his continued investigation into the tax practices of multinational pharmaceutical companies to abuse tax havens and avoid paying U.S. tax.

---

Wyden Continues Investigation Into Big Pharma Tax Practices

Following letter to AbbVie, Wyden requests information from Bristol Myers Squibb

Washington, D.C. – Senate Finance Committee Chair Ron Wyden, D-Ore., today continued his investigation in…